# Haplo-SCT vs ASCT With or Without Decitabine in AML CR1

> **NCT02059720** · PHASE3 · UNKNOWN · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 212 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **PROCEDURE:** HSCT

## Key facts

- **NCT ID:** NCT02059720
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2020-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02059720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02059720, "Haplo-SCT vs ASCT With or Without Decitabine in AML CR1". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02059720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*